World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
144
Citations
70900
World Ranking
1454
National Ranking
34

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Olivier Hermine is affiliated with Necker-Enfants Malades Hospital in France and specializes in medical research, with a primary focus in immunology, genetics, oncology, hematology, and pathology and forensic medicine. Their publications predominantly cover topics related to mast cells and histamine, lymphoma diagnosis and treatment, hemoglobinopathies and related disorders, T-cell and retrovirus studies, chronic lymphocytic leukemia research, immunodeficiency and autoimmune disorders, and COVID-19 clinical research studies.

Notable recent papers by Olivier Hermine include:

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia, 2020, JAMA Internal Medicine

While some frequently cited papers do not list Olivier Hermine as the primary author, these are closely related works in the field during recent years:

  • A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma, 2022, Nature Medicine
  • Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19, 2020, Blood
  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1, 2021, The Journal of Experimental Medicine

Frequent coauthors in Olivier Hermine's body of work include:

  • Morgane Cheminant
  • Steven Le Gouill
  • Michel Arock
  • Julien Rossignol
  • Catherine Thiéblemont

Major publication venues featured in Olivier Hermine's research output are:

  • Blood
  • HemaSphere
  • The Journal of Allergy and Clinical Immunology In Practice
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Hematological Oncology

The main field of study is medicine, under which Olivier Hermine's research spans a substantial number of publications, with notable contributions in immunology, which encompasses 213 works, followed by genetics (131), oncology (97), hematology (89), and pathology and forensic medicine (86).

Best Publications

  • Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

    Laurent Beaugerie;Nicole Brousse;Anne Marie Bouvier;Jean Frédéric Colombel

  • Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

    Olivier Hermine;François Lefrère;Jean-Pierre Bronowicki;Xavier Mariette

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells

    Frederic Geissmann;Catherine Prost;Jean-Paul Monnet;Michel Dy

  • Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

    Alexis A. Thompson;Mark C. Walters;Janet Kwiatkowski;John E.J. Rasko;John E.J. Rasko;John E.J. Rasko

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

    Olivier Hermine;Olivier Hermine;Xavier Mariette;Pierre-Louis Tharaux;Matthieu Resche-Rigon

  • Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

    M Shankar-Hari;C L Vale;P J Godolphin

  • Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting

    Kunihiro Tsukasaki;Olivier Hermine;Ali Bazarbachi;Lee Ratner

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    O Hermine;C Haioun;E Lepage;MF d'Agay

  • CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans

    Sandra Weller;Ahmad Faili;Corinne Garcia;Moritz C. Braun

  • Caspase Activation Is Required for Terminal Erythroid Differentiation

    Yael Zermati;Carmen Garrido;Sophie Amsellem;Serge Fishelson

  • Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation

    Felipe Suarez;Olivier Lortholary;Olivier Lortholary;Olivier Lortholary;Olivier Hermine;Olivier Hermine;Olivier Hermine;Marc Lecuit;Marc Lecuit;Marc Lecuit

  • High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

    Arnaud Jaccard;Philippe Moreau;Véronique Leblond;Xavier Leleu

  • Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma

    Olivier Hermine;Corinne Haioun;Eric Lepage;Marie-Françoise D'Agay

  • TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.

    Frederic Geissmann;Patrick Revy;Armelle Regnault;Yves Lepelletier

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

    Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin

  • Incidence and prognostic impact of c-Kit , FLT3 , and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

    N Boissel;H Leroy;B Brethon;N Philippe

  • Specific involvement of caspases in the differentiation of monocytes into macrophages.

    Olivier Sordet;Cédric Rébé;Cédric Rébé;Cédric Rébé;Stéphanie Plenchette;Stéphanie Plenchette;Stéphanie Plenchette;Yaël Zermati;Yaël Zermati;Yaël Zermati

Frequent Co-Authors

Ali Bazarbachi
Ali Bazarbachi American University of Beirut
Elizabeth Macintyre
Elizabeth Macintyre Necker-Enfants Malades Hospital
Ivan C. Moura
Ivan C. Moura Inserm : Institut national de la santé et de la recherche médicale
Nicole Brousse
Nicole Brousse Université Paris Cité
Alain Fischer
Alain Fischer Collège de France
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Stéphane Blanche
Stéphane Blanche Université Paris Cité
Antoine Gessain
Antoine Gessain Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but looking for flexible study options beyond traditional medical school, there are several online degree pathways worth exploring. Many students prefer programs that let them balance work, family, and study, especially when committing to a demanding healthcare career.

For nurses seeking an advanced degree, online dnp programs without clinicals offer a practical solution to further your education without extensive on-site requirements. Those starting their nursing journey can fast-track their entry into the profession through a 6 month lpn program online, making it possible to become a Licensed Practical Nurse (LPN) in less time.

If mental health is your passion, specialized psych np programs can help you pursue careers as a Psychiatric Mental Health Nurse Practitioner, addressing a critical need in healthcare. Alternatively, for those interested in the business side of healthcare, an health administration degree provides a pathway to leadership and management roles in a variety of settings.

Best Scientists Citing Olivier Hermine

Trending Scientists